MR 409, a selective growth hormone-releasing hormone (GHRH) agonist, exhibits notable neuroprotective properties by augmenting endogenous neurogenesis in cerebral ischemic mice and demonstrates the ability to inhibit in vivo lung cancer growth [1] [2] [3] [4].
Molecular Weight:
3395.91
CAS Number:
[1445155-39-4]
Formula:
C153H252N44O43
Target:
GHSR
T78023
* VAT and and shipping costs not included. Errors and price changes excepted
